HopeStage
Back to all studies
CompletedNCT05035316

Low-dose aspirin study for people with bipolarity

About this titleRead the official source — NCT05035316
Medication studyAges 18–65Denmark
The study in practice

Understand this study

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Listed locations
CopenhagenSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: January 20, 2022
Recruitment status
Completed
Enrollment listed in the registry
250
Sponsor
Lars Vedel Kessing
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Denmark
Age range
From 18 Years to 65 Years
Official registry ID
NCT05035316
Official title
Show the full official title

Effects of Low Dose Aspirin in Bipolar Disorder (The A-Bipolar RCT)

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Copenhagen

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Lars Vedel Kessing.

Did this study involve medication?

Yes. The study involved medication, including acetylsalicylic acid and Calcium.

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies